About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
H
Measuring Overall Severity of Myasthenia Gravis: Evidence for the Added Value of the MG Symptoms PRO
By
Henry J. Kaminski
2 Videos
75 views
August 28, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
05:14
argenx Neurology
Understanding Individualized Dosing of Two Treatments for Adult Pati…
Feat.
N. J. Silvestri
Featured Video
07:31
argenx Neurology
The MG-ADL Scale as a Clinical Tool: The Power of Patient Perspective
Feat.
S. Muppidi
Related Content
AUTOPLAY
ON
University of Utah Neurology
62nd Western Intermountain Neurological Organization (WINO) Conferen…
Fri, Sep 27, 2024
06:46
argenx Neurology
How to Administer and Use the MG-ADL Scale in Clinical Practice
Feat.
J. F. Howard Jr
09:17
argenx Neurology
Considerations for Treatment of Adult Patients with Anti-AChR Antibo…
Feat.
J. Durrani
50:07
ZINCARE
Overview of Neuromuscular Disorders
Feat.
S. Zimba
30:04
NYU Langone
Myasthenia Gravis: Treatment Update
Feat.
J. M. Bhatt
10:45
Nils Erik Gilhus
Individualized MG Treatment Based on Disease Pathogenesis
16:16
Alexis A. Lizarraga
Treatment Approach in Patients With Myasthenia Gravis
23:36
Raed Behbehani
Ocular Myasthenia Gravis: A Current Overview
40:06
Diana Greene-Chandos
Neuromuscular Disorders and Spinal Cord Injury in the ICU: Diagnosis…
27:47
Alessio Sarnataro
EAN 2024 Insights: Current Updates in Myasthenia Gravis
42:22
Houston Methodist
Advances in Treatments for Myasthenia Gravis
Feat.
E. Greene
29:20
Houston Methodist
2023 Overview of Myasthenia Gravis
Feat.
B. Liao
33:53
Ghazala Hayat
Antibodies in Myasthenia Gravis: How to Interpret It
19:54
Ileana Howard
Respiratory Considerations in Neuromuscular Disease
47:25
Houston Methodist
Respiratory Issues in Myasthenic Disease and Management
Feat.
M. Cao
48:34
Swedish
Myasthenia Gravis and Other Neuromuscular Junction Disorders
Feat.
C. Edmundson
09:00
Katherine C. Dodd
Mycophenolate and Methotrexate Are Better Tolerated Than Azathioprin…
48:05
Houston Methodist Hospital
Emerging Therapies for Neuromuscular Diseases in 2021: ALS, Dystroph…
Feat.
E. Greene
17:57
Penn Medicine
Single Institution Experience with Efgartigimod in Patients with Mya…
Feat.
M. Singer
46:48
Vera Bril
Myasthenia Gravis: Clinical and Research Updates
Feat.
C. Barnett-Tapia
41:17
Houston Methodist Hospital
Overview of Myasthenia Gravis
Feat.
S. Shroff
